Medpace Holdings (MEDP) Receivables (2015 - 2026)

Medpace Holdings (MEDP) has reported Receivables for 12 consecutive years, with $463.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables rose 20.61% year-over-year to $463.1 million; the trailing twelve-month figure through Jun 2026 stood at $463.1 million (up 20.61% YoY), and the FY2025 full-year result was $427.4 million, up 33.35% from the prior year.
• Receivables climbed to $463.1 million in Q2 2026 per MEDP's latest filing, from $418.8 million in the prior quarter.
• Across five years, Receivables topped out at $463.1 million in Q2 2026 and bottomed at $264.4 million in Q1 2022.
• Historically, Receivables has averaged $332.2 million across 5 years, with a median of $309.0 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Receivables jumped 40.31% in 2022, then dropped 3.97% in 2024.
• Over 5 years, Receivables stood at $293.8 million in 2022, then increased by 4.8% to $307.9 million in 2023, then rose by 4.11% to $320.5 million in 2024, then jumped by 33.35% to $427.4 million in 2025, then climbed by 8.34% to $463.1 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $463.1 million, $418.8 million, and $427.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.